Uvidem

Uvidem Uses, Dosage, Side Effects, Food Interaction and all others data.

Uvidem is a therapeutic specific immunostimulant developed by IDM Pharma in partnership with sanofi-aventis. It consists of mature dendritic cells loaded with lysates from melanoma tumor cell lines. It includes Dendritophages that are dendritic cells, a type of specialized immune cells derived from the patient's own white blood cells.

Table Of contents

• Uvidem
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Uvidem
Generic	IDD-3
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Investigated for use/treatment in melanoma.

How Uvidem works

Uvidem is well tolerated with evidence of efficacy and induction of immune response in patients with progressive metastatic melanoma.

Innovators Monograph

You find simplified version here Uvidem